<rss version="2.0">
<channel>
<title>IBTimes.com RSS Feed - LLY</title>
<description>International Business News - LLY</description>
<link>http://www.ibtimes.com</link>
<copyright>All articles are copyrighted by IBTimes.com</copyright>

<image>
	<title>The International Business Times - Business News, Updated daily</title> 
	<width>400</width> 
	<height>100</height> 
	<link>http://www.ibtimes.com/</link> 
	<url>http://www.ibtimes.com/images/top_logo_ibt2_3.gif</url> 
</image>


  <item>
  <title>Alkermes rises as analyst names it a 'Top Pick'</title>
  <description>Alkermes Inc. shares rose Friday after an analyst predicted stronger sales of its schizophrenia drug Risperdal Consta and good clinical data for a diabetes drug candidate.</description>
    <link>http://www.ibtimes.com/articles/20080516/alkermes-rises-as-analyst-names-it-a-top-pick.htm</link> 
  <pubDate>Fri, 16 May 2008 17:19:37 EDT</pubDate>
  </item>


  <item>
  <title>Eli Lilly says Alimta helps lung cancer patients</title>
  <description>Eli Lilly &amp; Co. said giving advanced lung cancer patients its Alimta drug after chemotherapy increased patients' survival without tumor recurrence or progression.</description>
    <link>http://www.ibtimes.com/articles/20080516/eli-lilly-says-alimta-helps-lung-cancer-patients.htm</link> 
  <pubDate>Fri, 16 May 2008 12:50:32 EDT</pubDate>
  </item>


  <item>
  <title>Pfizer names head of oncology business unit</title>
  <description>Pfizer Inc. late Wednesday said that it named Garry A. Nicholson to head the drug maker's new oncology business unit. Nicholson's responsibilities within the franchise include clinical development, commercial development, sales and marketing.</description>
    <link>http://www.ibtimes.com/articles/20080515/pfizer-names-head-of-oncology-business-unit.htm</link> 
  <pubDate>Thu, 15 May 2008 07:39:26 EDT</pubDate>
  </item>


  <item>
  <title>Disclosing drug makers payments to docs gets boost</title>
  <description>Legislation that would require prescription drug makers to disclose payments to doctors got a boost Tuesday when Eli Lilly and Co., broke ranks with the industry and endorsed the bill.</description>
    <link>http://www.ibtimes.com/articles/20080513/disclosing-drug-makers-payments-to-docs-gets-boost.htm</link> 
  <pubDate>Tue, 13 May 2008 16:57:36 EDT</pubDate>
  </item>


  <item>
  <title>OSI shares rise after posting 1Q profit on cancer drug sales</title>
  <description>Shares of OSI Pharmaceuticals rose Wednesday, a day after the biotechnology company beat Wall Street expectations on higher sales of its cancer drug Tarceva.</description>
    <link>http://www.ibtimes.com/articles/20080507/osi-shares-rise-after-posting-1q-profit-on-cancer-drug-sales.htm</link> 
  <pubDate>Wed, 07 May 2008 16:56:27 EDT</pubDate>
  </item>


  <item>
  <title>Sector Snap: Schering-Plough, Glaxo boost pharma stocks</title>
  <description>Positive earnings reports from Schering-Plough Corp. and GlaxoSmithKline PLC lifted big pharma stocks Wednesday after several days of mixed results from their peers.</description>
    <link>http://www.ibtimes.com/articles/20080423/sector-snap-schering-plough-glaxo-boost-pharma-stocks.htm</link> 
  <pubDate>Wed, 23 Apr 2008 12:51:22 EDT</pubDate>
  </item>


  <item>
  <title>Sector Wrap: Pharma sector down, Wyeth's Protonix sales drop</title>
  <description>The pharmaceutical sector slipped lower Tuesday, as drugmaker Wyeth said its first-quarter profit declined and generic competition slashed sales of blockbuster heartburn drug Protonix by 66 percent.</description>
    <link>http://www.ibtimes.com/articles/20080422/sector-wrap-pharma-sector-down-wyeths-protonix-sales-drop.htm</link> 
  <pubDate>Tue, 22 Apr 2008 15:41:07 EDT</pubDate>
  </item>


  <item>
  <title>Analysts: Drug maker earns get temporary lift amid problems</title>
  <description>Major drug companies saw their bottom lines buoyed by a weak dollar, one-time gains and other temporary items, but their shares still fell because of basic economic problems hurting the industry.</description>
    <link>http://www.ibtimes.com/articles/20080421/analysts-drug-maker-earns-get-temporary-lift-amid-problems.htm</link> 
  <pubDate>Mon, 21 Apr 2008 19:13:04 EDT</pubDate>
  </item>


  <item>
  <title>BofA, Eli Lilly, Mattel, National City big market movers</title>
  <description>Stocks that moved substantially or traded heavily Monday on the New York Stock Exchange and Nasdaq Stock Market: NYSE</description>
    <link>http://www.ibtimes.com/articles/20080421/bofa-eli-lilly-mattel-national-city-big-market-movers.htm</link> 
  <pubDate>Mon, 21 Apr 2008 17:05:21 EDT</pubDate>
  </item>


  <item>
  <title>Stocks mixed after Bank of America profit falls short</title>
  <description>Wall Street had a mixed performance Monday as investors regained a cautious stance after disappointing news from Bank of America Corp. and Midwest bank National City Corp., and after another record-breaking tear in oil prices.</description>
    <link>http://www.ibtimes.com/articles/20080421/stocks-mixed-after-bank-america-profit-falls-short.htm</link> 
  <pubDate>Mon, 21 Apr 2008 17:50:24 EDT</pubDate>
  </item>


  <item>
  <title>Stocks dip after Bank of America profit falls short</title>
  <description>Wall Street pulled back Monday as investors, who sent the major market indexes up 4 percent last week, reacted to a weaker-than-expected profit report from Bank of America Corp. and disappointing news from a smaller bank, National City Corp.</description>
    <link>http://www.ibtimes.com/articles/20080421/stocks-dip-after-bank-of-america-profit-falls-short.htm</link> 
  <pubDate>Mon, 21 Apr 2008 14:10:00 EDT</pubDate>
  </item>


  <item>
  <title>Court asks government's views on states' patent liability</title>
  <description>The Supreme Court on Monday asked the Bush administration to weigh in on a long-running fight between states and big business over whether states can be held liable for patent infringement.</description>
    <link>http://www.ibtimes.com/articles/20080421/court-asks-governments-views-on-states-patent-liability.htm</link> 
  <pubDate>Mon, 21 Apr 2008 11:48:30 EDT</pubDate>
  </item>


  <item>
  <title>Stocks decline after Bank of America profit falls short</title>
  <description>Wall Street pulled back Monday after a weaker-than-expected profit report from Bank of America Corp. stirred concerns about the health of corporate earnings.</description>
    <link>http://www.ibtimes.com/articles/20080421/stocks-decline-after-bank-of-america-profit-falls-short.htm</link> 
  <pubDate>Mon, 21 Apr 2008 10:36:27 EDT</pubDate>
  </item>


  <item>
  <title>Earnings roundup: Merck, Eli Lilly</title>
  <description>Among the earnings stories for Monday, April 21, from the AP Financial Desk: Top stories:</description>
    <link>http://www.ibtimes.com/articles/20080421/earnings-roundup-merck-eli-lilly.htm</link> 
  <pubDate>Mon, 21 Apr 2008 10:35:55 EDT</pubDate>
  </item>


  <item>
  <title>Pharma stocks open lower as broader market falls</title>
  <description>Shares of large pharmaceutical companies opened lower Monday as Eli Lilly &amp; Co.'s first-quarter profit disappointed investors and the broader market declined on wider corporate earnings concerns.</description>
    <link>http://www.ibtimes.com/articles/20080421/pharma-stocks-open-lower-as-broader-market-falls.htm</link> 
  <pubDate>Mon, 21 Apr 2008 10:12:23 EDT</pubDate>
  </item>


  <item>
  <title>Eli Lilly 1Q profit doubles, but falls short of expectations</title>
  <description>Drug maker Eli Lilly and Co. said strong sales for Cymbalta and Cialis helped double its first-quarter profit, but results missed Wall Street expectations.</description>
    <link>http://www.ibtimes.com/articles/20080421/eli-lilly-1q-profit-doubles-but-falls-short-of-expectations.htm</link> 
  <pubDate>Mon, 21 Apr 2008 09:46:08 EDT</pubDate>
  </item>


  <item>
  <title>Amylin 1Q loss grows as marketing and research costs rise</title>
  <description>Biotechnology company Amylin Pharmaceuticals Inc. said Monday its first-quarter loss widened on higher marketing costs for diabetes drugs Byetta and Symlin and preparations to market the once weekly diabetes drug exenatide.</description>
    <link>http://www.ibtimes.com/articles/20080421/amylin-1q-loss-grows-as-marketing-and-research-costs-rise.htm</link> 
  <pubDate>Mon, 21 Apr 2008 07:54:32 EDT</pubDate>
  </item>


  <item>
  <title>Eli Lilly 1Q profit doubles as Cialis, Cymbalta sales rise</title>
  <description>Eli Lilly says first-quarter profit doubled on strong growth in sales of depression treatment Cymbalta and impotence drug Cialis, as well as fewer charges.</description>
    <link>http://www.ibtimes.com/articles/20080421/eli-lilly-1q-profit-doubles-as-cialis-cymbalta-sales-rise.htm</link> 
  <pubDate>Mon, 21 Apr 2008 06:56:49 EDT</pubDate>
  </item>


  <item>
  <title>Closing Glance: Large-cap pharma stocks close higher</title>
  <description>
Shares of large pharmaceutical companies closed higher Friday as the broader market gained ground on positive earnings reports from Citigroup Inc. and Google Inc.

The American Stock Exchange's Phar...</description>
    <link>http://www.ibtimes.com/articles/20080418/closing-glance-large-cap-pharma-stocks-close-higher.htm</link> 
  <pubDate>Fri, 18 Apr 2008 16:41:13 EDT</pubDate>
  </item>


  <item>
  <title>Earnings Preview: Eli Lilly seen posting positive 1Q results</title>
  <description>
Eli Lilly &amp; Co. reports earnings for the first quarter on Monday. The following is a summary of key developments and analyst opinion related to the period.

OVERVIEW: Legal expenses could continue na...</description>
    <link>http://www.ibtimes.com/articles/20080418/earnings-preview-eli-lilly-seen-posting-positive-1q-results.htm</link> 
  <pubDate>Fri, 18 Apr 2008 12:03:07 EDT</pubDate>
  </item>


</channel>
</rss>